Fig. 3From: Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trialsMean random blood glucose concentrations from time of transplant to month 12 in (a) the ZEUS study and (b) the HERAKLES study. CsA, cyclosporine; PTDM, posttransplant diabetes mellitusBack to article page